Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Jul 04, 2024 1:38am
296 Views
Post# 36117607

Cause for opportunity, not concern

Cause for opportunity, not concern

First I have not been posting. Dealing with some very serious family health issues.
Today, I randomly came across a visual 12 month price chart of oncy.
A very small red spot in the left side, separated by a pointer showing existing price. Then on the right side a massive green line.
Decades ago, before the internet. Best stock price information was in the Saturday business section of local or larger newspapers.
i used to scan the highs & lows for the week & year as listed. Looking for stocks trading as close to bottom as possible, with a larger gap.
Picking one or two, I'd talk with my stockbroker on the Monday.
A few simple questions.. What does company X do? 

Is there a valid reason why the price is down considerably form the year high?
Anything expected to change to correct for the drop?
onc, is working to prove & get approve Pelareorep for cancer treatments.
 We certainly have an amazing upside opportunity & graphically not much left  on the downside.
Second question, any valid reason to be down from the year , 3 year 5=year high?
One could come up with ample feelings or thoughts. 

Boil everything away, only one reason. Delayed milestones required to get Peal to Market & partnership opportunities.
last question. 

any expected changes to overcome the drop.
since delays of Pela progress is the main motivation of price drop. 
what can or has changed to move Pelareorep closer to aporoval
.
last few months
new VP business development hired, a change for sure
recent FDA type C meeting, uodate & approval of various corporate & supporting colaborators.
additional arm into bracelet study. Coming from a $5 million grant. Also in trial with bio therapy  Roche , tecentriq.
Announcement of CGAR support is pending pancreatic phase 3 trial.
All said, ample reasons to see improvements in the key driver of the  price.

Very methodical, logical points.
on which alone. I'd be quite happy to be buying.

one thng I rarely looked at, was potential value of upside.
that created a lot of problems for me. Holding too long, or selling to soon.
i don't have a sell price in mind fo4 Onc. Or a sell date.
i do have two activities that will have me selling.
obvious a buyout. Decision made.
or possibly sell some portion on a partnership.
Certianly worth much more than present ranges.
Lots of opportunities, time will tell.
yes it has too long. Satin* thst, niot one jot of bad news indicatyey won't get to market.
Bottom line?
belive in Pelareorep getting to market. Buy or hold.
dont believe Pela will get to market sell or don't buy.

 

<< Previous
Bullboard Posts
Next >>